Gender differences in secondary prevention of coronary heart disease: reasons to worry or not?

Related Experiment Videos

Peter Nilsson1, Hans Brandström, Hans Lingfors

  • 1Department of Medicine, University Hospital, Malmö, Sweden. Peter.Nilsson@medforsk.mas.lu.se

Scandinavian Journal of Primary Health Care
|April 30, 2003
PubMed

Insights

This study found no significant gender differences in cardiovascular risk factors or treatment for patients undergoing secondary prevention. However, women showed higher blood pressure and cholesterol levels, despite increased lifestyle education participation.

Area of Science:

  • Cardiovascular Medicine
  • Public Health
  • Health Services Research

Background:

  • Secondary prevention of coronary heart disease (CHD) is crucial for patient outcomes.
  • Understanding gender-specific differences in risk factors and treatment is essential for optimizing care.
  • Clinical practice patterns in CHD secondary prevention require ongoing evaluation.

Purpose of the Study:

  • To investigate potential gender disparities in cardiovascular risk factors.
  • To analyze gender differences in treatment patterns for secondary CHD prevention.
  • To reflect current clinical practice in Sweden for CHD secondary prevention.

Main Methods:

  • An observational national study was conducted over 3 years in Sweden.
  • Included patients eligible for secondary prevention of coronary heart disease (CHD).
  • Data collected on lifestyle, drug treatment, and risk factors at 12 months post-intervention.

Main Results:

  • No major gender differences in risk factor levels or cardiovascular drug treatment at 12 months.
  • Female patients engaged more in lifestyle educational programs but had higher smoking rates.
  • Female patients exhibited higher blood pressure, total cholesterol, and HDL cholesterol levels.

Conclusions:

  • Gender equality in lipid control and medical treatment access was observed in Swedish secondary CHD prevention.
  • Despite overall equality, specific risk factor profiles warrant attention for targeted interventions.
  • The findings support the established level of care for secondary CHD prevention in Sweden.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...